ITOS   $7.67  -1.67% Market Closed After Close 7.66 -0.13%

Iteos Therapeutics Inc
Total Cash 571.26M
totalCashPerShare 15.641
EBITDA -139.26M
Total Debt 5.52M
quickRatio 17.7
currentRatio 18.075
Total Revenue 35.00M
debtToEquity 0.831
Revenue/Share 0.952
ROA -0.12051
ROE -0.16799
grossProfits
freeCashflow -96.24M
operatingCashflow -113.98M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -0.37923
profitMargins 0.0
enterpriseValue -229.01M
forwardPE -1.6076922
floatShares 23.93M
sharesOutstanding 36.52M
sharesShort 3.82M
sharesShortPriorMonth 2.51M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.10%
Short Ratio help_outline 4.31%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 18.178
Price To Book help_outline 0.52
earningsQuarterlyGrowth
netIncomeToCommon -108.14M
trailingEps -2.96%
forwardEps -5.85%
enterpriseToEbitda 1.64
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.89 3Q 2024
institutionsCount 211
lastUpdated Nov. 7, 2024, 3:19 a.m.